IONS Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals Inc is the RNA-targeted drug discovery and development company. Its broad pipeline consists of 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe, and rare diseases.

$38.06  +1.04 (2.81%)
As of 07/01/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/21/2001
Outstanding shares:  141,797,854
Average volume:  906,076
Market cap:   $5,249,356,555
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BDJ0LS6
Valuation   (See tab for details)
PE ratio:   -1,386.32
PB ratio:   7.60
PS ratio:   6.24
Return on equity:   -0.55%
Net income %:   -0.46%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy